Inspire Medical Systems (INSP) Cash from Operations Growth (1y) (2018 - 2026)
Inspire Medical Systems (INSP) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.80 Bn | 125.92 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.54 Bn | 67.08 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.37 Bn | 44.70 Bn | 1.29 Bn | -84.38% |
| 6 | Dexcom | 28.41 Bn | 27.30 Bn | 750.30 Mn | 185.96% |
| 7 | GE HealthCare Technologies | 28.33 Bn | 26.04 Bn | 1.98 Bn | 16.00% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 122.43% |
| 10 | Inspire Medical Systems | 1.47 Bn | 1.18 Bn | 176.91 Mn | 291.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 291.69% |
| Dec 31, 2025 | -24.16% |
| Sep 30, 2025 | 31.07% |
| Jun 30, 2025 | 3,541.03% |
| Mar 31, 2025 | -175.65% |
| Dec 31, 2024 | 300.65% |
| Sep 30, 2024 | 1,337.14% |
| Jun 30, 2024 | -101.53% |
| Mar 31, 2024 | 759.23% |
| Dec 31, 2023 | -10.39% |
| Sep 30, 2023 | -66.93% |
| Jun 30, 2023 | 185.52% |
| Mar 31, 2023 | 89.46% |
| Dec 31, 2022 | 2,525.20% |
| Sep 30, 2022 | 3,355.03% |
| Jun 30, 2022 | 41.13% |
| Mar 31, 2022 | -22.57% |
| Dec 31, 2021 | 117.86% |
| Sep 30, 2021 | 96.21% |
| Jun 30, 2021 | 59.95% |